Recommendations from the EGAPP Working Group: Testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors. EGAPP Recommendation Statement
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors. EGAPP Recommendation Statement. Genet. Med. 9, 819-825 (2007).
Integrating molecular medicine into the U.S. health-care system: Opportunities, barriers and policy challenges
Deverka, P.A., Doksum T. & Carlson, R.J. Integrating molecular medicine into the U.S. health-care system: opportunities, barriers and policy challenges. Clin. Pharmacol. Ther. 82, 427-434 (2007).
Centers for Medicare and Medicaid Services. National Coverage Determinations with Data Collection as a Condition of Coverage: Coverage with Evidence Development 〈http://www.cms.hhs.gov/mcd/ncpc_view_document.asp?id= 8〉 (12 July 2006).
Centers for Medicare and Medicaid Services. National Coverage Determinations with Data Collection as a Condition of Coverage: Coverage with Evidence Development 〈http://www.cms.hhs.gov/mcd/ncpc_view_document.asp?id= 8〉 (12 July 2006).
7
2142776334
Defining the balance of risk and benefit in the era of genomics and proteomics
Califf, R.M. Defining the balance of risk and benefit in the era of genomics and proteomics. Health Affairs 23, 77-87 (2004).
US Department of Health and Human Services. Health Information Technology: Personalized Healthcare Workgroup 〈http://www.hhs.gov/healthit/ ahic/healthcare〉 (3 March 2008).
